NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 45 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $10,097,100 | -15.1% | 7,500,000 | 0.0% | 0.05% | -12.5% |
Q4 2022 | $11,887,050 | +11.9% | 7,500,000 | 0.0% | 0.06% | +14.3% |
Q3 2022 | $10,626,000 | +6.7% | 7,500,000 | 0.0% | 0.05% | +14.0% |
Q2 2022 | $9,955,000 | +1.9% | 7,500,000 | 0.0% | 0.04% | +16.2% |
Q1 2022 | $9,765,000 | +3.3% | 7,500,000 | 0.0% | 0.04% | +5.7% |
Q4 2021 | $9,449,000 | -5.8% | 7,500,000 | 0.0% | 0.04% | -20.5% |
Q3 2021 | $10,031,000 | +0.6% | 7,500,000 | 0.0% | 0.04% | -4.3% |
Q2 2021 | $9,967,000 | -1.7% | 7,500,000 | 0.0% | 0.05% | -16.4% |
Q1 2021 | $10,139,000 | -65.8% | 7,500,000 | -64.7% | 0.06% | -68.0% |
Q4 2020 | $29,654,000 | +1.0% | 21,268,000 | 0.0% | 0.17% | -9.0% |
Q3 2020 | $29,371,000 | -16.8% | 21,268,000 | 0.0% | 0.19% | -24.1% |
Q2 2020 | $35,286,000 | +5.4% | 21,268,000 | -18.6% | 0.25% | -5.3% |
Q1 2020 | $33,463,000 | -29.5% | 26,136,000 | -15.4% | 0.26% | +11.9% |
Q4 2019 | $47,492,000 | +12.0% | 30,906,000 | 0.0% | 0.24% | +1.7% |
Q3 2019 | $42,391,000 | +3.7% | 30,906,000 | 0.0% | 0.23% | +1.8% |
Q2 2019 | $40,865,000 | +25.1% | 30,906,000 | +28.2% | 0.23% | +11.3% |
Q1 2019 | $32,660,000 | +15.3% | 24,105,000 | +0.0% | 0.20% | +9.1% |
Q4 2018 | $28,333,000 | -31.6% | 24,100,000 | 0.0% | 0.19% | -18.0% |
Q3 2018 | $41,405,000 | +57.7% | 24,100,000 | +33.1% | 0.23% | +42.5% |
Q2 2018 | $26,259,000 | – | 18,100,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TENOR CAPITAL MANAGEMENT Co., L.P. | 45,447,000 | $60,497,000 | 1.31% |
SHENKMAN CAPITAL MANAGEMENT INC | 4,366,000 | $5,924,000 | 0.54% |
Aequim Alternative Investments LP | 7,609,000 | $10,088,000 | 0.43% |
MACKAY SHIELDS LLC | 27,806,000 | $37,405,000 | 0.35% |
Weiss Asset Management LP | 10,000,000 | $13,290,000 | 0.33% |
WOLVERINE ASSET MANAGEMENT LLC | 13,230,000 | $17,541,000 | 0.13% |
Polar Asset Management Partners Inc. | 7,500,000 | $9,942,000 | 0.10% |
LORD, ABBETT & CO. LLC | 22,141,000 | $29,732,000 | 0.07% |
Calamos Advisors LLC | 7,500,000 | $9,967,000 | 0.05% |
D. E. Shaw & Co., Inc. | 39,270,000 | $52,046,000 | 0.04% |